nostrum codeine syrup​

Nostrum codeine syrup is a prescription opioid-containing cough preparation manufactured by Nostrum Laboratories and formulated for the short-term management of persistent, non-productive cough. The defining pharmacologic component is codeine phosphate, an opioid agonist that acts centrally on the medullary cough center to suppress the cough reflex. Because it contains codeine—a Schedule II or III controlled substance in many jurisdictions—nostrum codeine syrup is regulated, dispensed only with a valid prescription, and intended for carefully selected patients under medical supervision.

nostrum cough syrup​

From a clinical standpoint, nostrum cough syrup​ is typically reserved for cases in which first-line, non-opioid antitussives (such as dextromethorphan or benzonatate) have not provided adequate relief. Clinicians may consider it when coughing is severe enough to disrupt sleep, impair daily functioning, or exacerbate chest discomfort. It is not designed for routine use in mild colds, nor is it appropriate for chronic cough without a defined diagnosis. The decision to prescribe involves evaluating symptom severity, patient comorbidities, and potential risks associated with opioid therapy.

nostrum syrup​

The therapeutic action of nostrum syrup derives from codeine phosphate, a naturally occurring opiate alkaloid derivative. Codeine exerts its antitussive effect by binding to μ-opioid receptors in the central nervous system, thereby elevating the threshold required to trigger the cough reflex. This central suppression reduces the frequency and intensity of coughing episodes, particularly those that are dry and irritating rather than productive.

Pharmacokinetically, codeine undergoes hepatic metabolism—primarily via the CYP2D6 enzyme pathway—into morphine and other metabolites. Genetic variability significantly influences patient response: “ultra-rapid metabolizers” may convert codeine to morphine more efficiently, increasing the risk of respiratory depression, while “poor metabolizers” may experience limited therapeutic benefit. This metabolic variability underscores why nostrum codeine syrup must be used under professional oversight rather than self-directed dosing.

Indications and Appropriate Use

Nostrum codeine syrup is generally indicated for short-term relief of acute cough associated with upper respiratory tract infections, bronchitis, or similar inflammatory conditions. It is most appropriate for dry, non-productive coughs. Suppressing a productive cough—where mucus clearance is clinically necessary—can be counterproductive and may prolong infection or worsen pulmonary function.

In most regulatory environments, opioid-containing cough syrups are contraindicated in young children due to increased risk of serious breathing complications. Adult use is more common, and even then, treatment duration is typically limited to the shortest effective period. Long-term use for chronic cough is generally discouraged unless managed by a specialist with careful monitoring.